DK0792160T3 - Glial-afledt neurofoisk faktor som et neurobeskyttende middel - Google Patents
Glial-afledt neurofoisk faktor som et neurobeskyttende middelInfo
- Publication number
- DK0792160T3 DK0792160T3 DK95935548T DK95935548T DK0792160T3 DK 0792160 T3 DK0792160 T3 DK 0792160T3 DK 95935548 T DK95935548 T DK 95935548T DK 95935548 T DK95935548 T DK 95935548T DK 0792160 T3 DK0792160 T3 DK 0792160T3
- Authority
- DK
- Denmark
- Prior art keywords
- glial
- derived
- factor
- neurophysical
- gdnf
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34082194A | 1994-11-15 | 1994-11-15 | |
PCT/IB1995/001004 WO1996014861A1 (en) | 1994-11-15 | 1995-11-13 | Glial derived neurotrophic factor as a neuroprotective agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0792160T3 true DK0792160T3 (da) | 2001-11-19 |
Family
ID=23335068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95935548T DK0792160T3 (da) | 1994-11-15 | 1995-11-13 | Glial-afledt neurofoisk faktor som et neurobeskyttende middel |
Country Status (13)
Country | Link |
---|---|
US (1) | US5733875A (es) |
EP (1) | EP0792160B1 (es) |
JP (1) | JPH10508839A (es) |
AT (1) | ATE205088T1 (es) |
AU (1) | AU691349B2 (es) |
CA (1) | CA2204911C (es) |
DE (1) | DE69522578T2 (es) |
DK (1) | DK0792160T3 (es) |
ES (1) | ES2159647T3 (es) |
IL (1) | IL115966A (es) |
PT (1) | PT792160E (es) |
WO (1) | WO1996014861A1 (es) |
ZA (1) | ZA959714B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184200B1 (en) * | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
AU1121997A (en) * | 1995-11-29 | 1997-06-19 | Amgen, Inc. | Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product |
US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
TR199901734T2 (xx) | 1996-11-15 | 2000-01-21 | Genentech, Inc. | N�rotrofinlerin ar�t�lmas�. |
US6277820B1 (en) | 1998-04-09 | 2001-08-21 | Genentech, Inc. | Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells |
DE60002496T2 (de) * | 1999-10-29 | 2004-03-25 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Verwendung von gdnf für behandlung von hornhautdefekten |
US20040197900A1 (en) * | 2003-04-04 | 2004-10-07 | Arnon Rosenthal | Foggy |
HUE030903T2 (en) | 2006-04-25 | 2017-06-28 | Univ California | Administration of growth factors for the treatment of CNS disorders |
EP2023949A4 (en) * | 2006-04-26 | 2009-08-26 | Univ California | COMPOSITIONS AND METHODS FOR THE DELIVERY OF NEUROTHERAPY OF HIGH MOLECULAR WEIGHT ENHANCED BY CONVECTION |
WO2009128057A2 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
EP2968462B1 (en) | 2013-03-15 | 2020-12-23 | The Jackson Laboratory | Methods for promoting wound healing and hair growth |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
CA3043179A1 (en) | 2016-11-10 | 2018-05-17 | Keros Therapeutics, Inc. | Gdnf fusion polypeptides and methods of use thereof |
EP3973979A1 (en) * | 2020-09-25 | 2022-03-30 | The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth | A tight junction (zonulae occludentes) protein for use in treating or preventing epilepsy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993006116A1 (en) * | 1991-09-20 | 1993-04-01 | Syntex-Synergen Neuroscience Joint Venture | Glial derived neurotrophic factor |
FR2717824B1 (fr) * | 1994-03-25 | 1996-04-26 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
-
1995
- 1995-05-22 US US08/446,383 patent/US5733875A/en not_active Expired - Lifetime
- 1995-11-12 IL IL11596695A patent/IL115966A/xx not_active IP Right Cessation
- 1995-11-13 AT AT95935548T patent/ATE205088T1/de not_active IP Right Cessation
- 1995-11-13 JP JP8515884A patent/JPH10508839A/ja not_active Ceased
- 1995-11-13 ES ES95935548T patent/ES2159647T3/es not_active Expired - Lifetime
- 1995-11-13 DK DK95935548T patent/DK0792160T3/da active
- 1995-11-13 WO PCT/IB1995/001004 patent/WO1996014861A1/en active IP Right Grant
- 1995-11-13 AU AU37528/95A patent/AU691349B2/en not_active Expired
- 1995-11-13 EP EP95935548A patent/EP0792160B1/en not_active Expired - Lifetime
- 1995-11-13 CA CA002204911A patent/CA2204911C/en not_active Expired - Fee Related
- 1995-11-13 DE DE69522578T patent/DE69522578T2/de not_active Expired - Fee Related
- 1995-11-13 PT PT95935548T patent/PT792160E/pt unknown
- 1995-11-15 ZA ZA9509714A patent/ZA959714B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2204911A1 (en) | 1996-05-23 |
CA2204911C (en) | 2002-07-23 |
WO1996014861A1 (en) | 1996-05-23 |
EP0792160A1 (en) | 1997-09-03 |
AU691349B2 (en) | 1998-05-14 |
ES2159647T3 (es) | 2001-10-16 |
JPH10508839A (ja) | 1998-09-02 |
ATE205088T1 (de) | 2001-09-15 |
AU3752895A (en) | 1996-06-06 |
IL115966A (en) | 1999-11-30 |
DE69522578D1 (de) | 2001-10-11 |
US5733875A (en) | 1998-03-31 |
IL115966A0 (en) | 1996-01-31 |
ZA959714B (en) | 1997-10-15 |
PT792160E (pt) | 2002-02-28 |
DE69522578T2 (de) | 2002-07-11 |
EP0792160B1 (en) | 2001-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0792160T3 (da) | Glial-afledt neurofoisk faktor som et neurobeskyttende middel | |
CA2098076A1 (en) | Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates | |
HUP0203198A2 (hu) | Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása | |
HUP0100606A2 (hu) | Keményített ricinusolajat tartalmazó tartós hatású injektálható készítmény | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
HUP0003323A2 (hu) | Vorikonazolt tartalmazó gyógyászati készítmények | |
MX9207495A (es) | Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ATE178793T1 (de) | L-dopa ester-enthaltende zusammensetzung | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
DE69631609D1 (en) | Tricyclische erythromycinderivate | |
HUP0103781A2 (hu) | Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák | |
HUP0004282A2 (hu) | 2-Halogén-6-0-szubsztituált ketolidszármazékok | |
CA2459470A1 (en) | Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use | |
ES2132101T3 (es) | Procedimiento para la preparacion de un medicamento destinado a la administracion por via oral o topica en el tratamiento de leishmaniasis. | |
YU49215B (sh) | Primena flupirtina za dobijanje medikamenta za tretman neurodegenerativnih oboljenja | |
IL97796A0 (en) | Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation | |
TW324662B (en) | Benzamide-containing pharmaceutical composition | |
BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
UA42719C2 (uk) | Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб | |
UA41285C2 (uk) | Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність | |
BR9809519A (pt) | Sal, processo para fabricação e uso do mesmo, formulação farmacêutica, e, processo para prevenção ou tratamento de distúrbios cns e perturbações médicas relacionadas | |
WO1999045909A3 (en) | Use of nitrone compounds for the inhibition of angiogenesis | |
CA2192822A1 (en) | Use of immunosuppressive agents for the treatment of schizophrenia |